MGMT autoantibodies as a potential prediction of recurrence and treatment response biomarker for glioma patients

BACKGROUND: Cancer‐specific autoantibodies found in serum of cancer patients have been characterized as potential predictors of the high risk of recurrence and treatment response. The objective of this study is to investigate the clinical utility of serum O‐6‐methylguanine‐DNA methyltransferase (MGM...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Haibin, Deng, Zhitong, Wang, Hao, Li, Xuetao, Sun, Ting, Tao, Zhennan, Yao, Lin, Jin, Yanping, Wang, Xiaoying, Yang, Lan, Ma, Hongwei, Huang, Yulun, Zhou, Youxin, Du, Ziwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675704/
https://www.ncbi.nlm.nih.gov/pubmed/31210005
http://dx.doi.org/10.1002/cam4.2346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675704/
https://www.ncbi.nlm.nih.gov/pubmed/31210005
http://dx.doi.org/10.1002/cam4.2346

Ejemplares similares